GlucoTrack, Inc.
GCTKGlucoTrack is a medical device company dedicated to developing an implantable continuous blood glucose monitor (CBGM) for individuals with Type 1 and Type 2 diabetes.
Table of contents
Earnings
Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
GlucoTrack is a medical device company dedicated to developing an implantable continuous blood glucose monitor (CBGM) for individuals with Type 1 and Type 2 diabetes. The company's core technology utilizes an intravascular approach to provide real-time blood glucose measurements with zero lag time and a projected sensor longevity of up to three years. Their mission is to eliminate the pain and inconvenience of conventional finger-stick devices and short-term wearable sensors through a long-term, fully implantable solution.
GlucoTrack is an early-stage clinical developer aiming to disrupt the market with a long-term, intravascular implantable sensor that offers superior longevity and accuracy compared to existing transcutaneous systems.
Questions, answered.
- What is GlucoTrack, Inc.'s market cap?
- GlucoTrack, Inc. (GCTK) has a market capitalization of $2.0M and trades on NASDAQ.
- Who are GlucoTrack, Inc.'s competitors?
- GlucoTrack, Inc.'s key competitors include Senseonics Holdings, Inc., Abbott Laboratories, Medtronic, and others. These companies compete in similar markets and product categories.
- Who does GlucoTrack, Inc. partner with?
- GlucoTrack, Inc.'s notable partners include The Technology Partnership, British Standards Institute.
- Where is GlucoTrack, Inc. headquartered?
- GlucoTrack, Inc. is headquartered in Israel and employs approximately 6 people. It has been publicly traded since 2000.